Objectives: Serum protein binding is critical for understanding the pharmacology of antimicrobial agents. Tigecycline and eravacycline were previously reported to have atypical non-linear protein binding; the percentage of free fraction decreased with increasing total concentration. In this study, we extended the investigation to other tetracyclines and examined the factors that might impact protein binding.
Introduction
Serum protein binding is critical for understanding the pharmacokinetics and pharmacodynamics of antimicrobial agents. Only the free fraction is able to penetrate into extravascular space and exert antimicrobial effects. Antimicrobial agents may show non-linear protein binding due to the saturation of binding sites, and typically the percentage of free fraction increases with increasing total concentration. 1, 2 However, an opposite phenomenon was reported recently in tigecycline and eravacycline. [3] [4] [5] It was recently proposed that the phenomenon could be due to these tetracyclines chelating divalent metal ions. 6 It is possible that other tetracyclines would also have the same property (i.e. a class effect). In this study, we investigated different factors that might impact binding of minocycline to serum proteins.
Materials and methods
Mouse and human sera were obtained from Equitech-Bio, Inc. (Kerrville, TX, USA). The sera were thawed once after purchase and stored at #20 C.
Minocycline hydrochloride, sodium hydroxide, HEPES, dipotassium phosphate (K 2 HPO 4 ) and monopotassium phosphate (KH 2 PO 4 ) powder were purchased from Sigma-Aldrich (St Louis, MO, USA). CMA 12 Elite Microdialysis Probe was a product of CMA Microdialysis (reference number 8010434; Stockholm, Sweden). The semipermeable membrane (20 000 Da cut-off) was made of polyarylethersulfone. The serum protein bindings of minocycline, doxycycline and levofloxacin were determined by in vitro microdialysis as described previously. 3 Briefly, a probe was inserted into a reservoir tube (containing serum spiked with an antimicrobial agent, incubated at 37 C). The perfusion medium was perfused through the probe at a flow rate of 1.5 lL/min. The system was equilibrated for 30 min, and then dialysates were collected between 30-40 and 40-50 min. Concurrent samples from the reservoir tube were also collected at 30, 40 and 50 min. Recovery of the microdialysis system was determined similarly and separately for each experiment; the reservoir tube was filled with a perfusion medium instead of serum. To minimize the non-specific binding of drugs to the tubing and membrane, the system was preconditioned by the same setup for 50 min. The experiments were performed at least twice on different days and the free fraction was calculated by the average of the results. The serum protein bindings were calculated by the following equations: The drug concentrations of all the samples were determined by validated LC-MS/MS methods. The methods to assay minocycline and doxycycline were described previously, 7 though were here slightly modified and revalidated to cover the range of 0.125-64 mg/L. Levofloxacin was analysed by the same LC-MS/MS method with a different sample preparation process. Briefly, 10 lL of a serum sample was mixed with 10 lL distilled water, 20 lL internal standard (ciprofloxacin in 1% ammonium hydroxide, 8 mg/L) and 170 lL acetonitrile. After vortexing for 15 s, the samples were centrifuged for 15 min at 18 000 g. A 20 lL aliquot of each supernatant was transferred to a new tube, and mixed with 220 lL distilled water. The samples were then ready for analysis; the injection volume was 3 lL. The linear range of levofloxacin detection was 0.05-64 mg/L.
Results
The protein binding of minocycline in mouse serum was studied at four concentrations (0.5, 5, 15 and 50 mg/L), and using four perfusion media: saline [sterile 0.9% (w/v) sodium chloride solution], 0.1 M HEPES buffer (pH 7.4, adjusted by sodium hydroxide), and 0.1 and 1 M PBS (pH 7.4). Both sterile and unprocessed mouse sera were used in the study, and no difference between these was observed. Free fractions of minocycline are shown in Figure 1 . For all the perfusion media examined, the values decreased with the increase in total minocycline concentrations. It is noteworthy that the binding values varied among various perfusion media using the same total minocycline concentration. Compared with the buffer groups, the saline group had considerably lower free fraction values. Similar experiments were performed using human serum and a consistent trend was observed to that in mouse serum (Figure 2a) . Finally, the protein bindings of doxycycline and levofloxacin in mouse serum were also determined at three concentrations (0.5, 5 and 50 mg/L), using saline as the perfusion medium. The free fractions of doxycycline and levofloxacin in mouse serum are shown in Figure 2 (b). Doxycycline had a similar trend of concentration-dependent protein binding, but the free fractions were slightly higher than that of minocycline. On the contrary, the protein binding values for levofloxacin were similar when comparing three different concentrations, and consistent with previously reported values (24%-38%). 8 
Discussion
Tigecycline and eravacycline were previously reported to exhibit atypical non-linear serum protein binding: the free fraction decreased with increasing total concentration. In this study, we extended the investigations to other tetracyclines and examined if this pattern of protein binding could be a generalized class effect.
Within a clinically achievable concentration range, minocycline and doxycycline were found to exhibit the same trend of protein binding as tigecycline. This atypical non-linear protein binding hence appears consistent across several tetracyclines. The serum protein binding of minocycline is usually accepted as Protein binding of minocycline JAC 76% as measured by ultrafiltration, 9 and is similar to our results using PBS with a low minocycline concentration. If the atypical non-linear protein binding is confirmed, the use of tetracyclines for the treatment of bacteraemia should be re-evaluated. This is especially relevant for pathogens with low-to intermediatelevel resistance, as higher doses may not yield better therapeutic outcomes. Moreover, our results also suggested that the choice of perfusion media might also have an impact on the microdialysis results. Therefore, the detailed conditions of the microdialysis experiments require further optimization/standardization. Correlating the results from in vitro systems to in vivo microdialysis should also be considered.
In summary, serum protein binding of minocycline is atypically concentration dependent. In addition, the microdialysis results can vary considerably depending on the perfusion medium used. To understand the mechanism(s) and clinical implications of serum protein binding to minocycline, additional studies are warranted.
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